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a b s t r a c t
Mechanical cell properties play an important role in many basic biological functions, including motility,
adhesion, proliferation and differentiation. There is a growing body of evidence that the mechanical cell
phenotype can be used for detection and, possibly, treatment of various diseases, including cancer.
Understanding of pathological mechanisms requires investigation of the relationship between consti-
tutive properties and major structural components of cells, i.e., the nucleus and cytoskeleton. While the
contribution of actin und microtubules to cellular rheology has been extensively studied in the past, the
role of intermediate ﬁlaments has been scarcely investigated up to now. Here, for the ﬁrst time we
compare the effects of drug-induced disruption of actin and vimentin intermediate ﬁlaments on
mechanical properties of suspended NK cells using high-throughput deformability measurements and
computational modeling. Although, molecular mechanisms of actin and vimentin disruption by the
applied cytoskeletal drugs, Cytochalasin-D and Withaferin-A, are different, cell softening in both cases
can be attributed to reduction of the effective density and stiffness of ﬁlament networks. Our
experimental data suggest that actin and vimentin deﬁcient cells exhibit, in average, 41% and 20%
higher deformability in comparison to untreated control. 3D Finite Element simulation is performed to
quantify the contribution of cortical actin and perinuclear vimentin to mechanical phenotype of the
whole cell. Our simulation provides quantitative estimates for decreased ﬁlament stiffness in drug-
treated cells and predicts more than two-fold increase of the strain magnitude in the perinuclear
vimentin layer of actin deﬁcient cells relatively to untreated control. Thus, the mechanical function of
vimentin becomes particularly essential in motile and proliferating cells that have to dynamically
remodel the cortical actin network. These insights add functional cues to frequently observed over-
expression of vimentin in diverse types of cancer and underline the role of vimentin targeting drugs,
such as Withaferin-A, as a potent cancerostatic supplement.
& 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
The structural and molecular organization of cells is highly
dynamic and undergoes permanent adaptive changes as a result of
integration of environmental signals and evolutionary conserved
molecular-genetic clues. To dissect the contribution of one particular
molecular component to the constitutive phenotype of the whole cell,
a number of biological and technical factors have to be considered.
Below, we give an overview over the key aspects that played a role by
motivation, design and implementation of the present study.
1.1. Overview of cytoskeletal ﬁlaments
Three major groups of cytoskeletal ﬁlaments, i.e., actin ﬁla-
ments (AF), microtubules (MT) and intermediate ﬁlaments (IF), are
known to maintain mechanical cellular integrity. Besides differ-
ences in molecular structure and function, each group of cyto-
skeletal ﬁlaments has its particular intracellular location, topolo-
gical organization and material properties. In non-adherent cell
lines, AF build a cortical layer beneath the cell membrane which
serves as major mechanical barrier between the cellular exterior
and interior (Alberts et al., 2007). In adherent cells, AF together
with myosin and interlinking proteins form a dynamic scaffold
providing the cell with mechanical stability and ﬂexibility on
variable substrates (Stamenovic and Ingber, 2002). Intermediate
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ﬁlaments represent a large group of polymers with 9–11 nm in
diameter which lays between 7 nm of AF and 25 nm of MT. In this
study, we focus on vimentin intermediate ﬁlaments (VIF) that
belong to the type III out of six different IF families. VIF are known
to assemble a protective network of ﬁbers around the chromatin-
bearing cell nucleus (Aubin et al., 1980) and also serve a substrate
for a number of cancer-relevant kinases (Satelli and Li, 2011).
Upregulation of vimentin is observed in cells undergoing epithe-
lial–mesenchymal transition (Lee et al., 2006) in a wide range of
cancer types and seems to correlate with tumor aggressiveness
and poor prognosis (Yamashita et al., 2013). Furthermore, all three
groups of cytoskeletal ﬁlaments can form tight interconnections,
especially, in adherent, motile and mechanosensitive cells (Fuchs
and Karakesisoglou, 2001).
1.2. Mechanical properties of cytoskeletal ﬁlaments
Rheological measurements of actin, tubulin and vimentin
polymers indicate that AF and VIF have the largest contribution
to the cellular stiffness at low and high strain rates, respectively
(Janmey et al., 1991). AF have the highest stiffness among all
cytoskeletal ﬁlaments and determine the elastic cell response at
the relatively low strain rates of up to 20%. In contrast, VIF begin to
stiffen at signiﬁcantly higher strain rates and continue to exhibit
intact elastic response even under surprisingly high deformation
rates of more than 50%. The remarkable vimentin elasticity is
ascribed to the multi-scale hierarchical structure of VIF which
enables a cascaded activation of different deformation mechan-
isms over several orders of spatial magnitude (Qin et al., 2009) as
well as to the effective density (Bertaud et al., 2010) and the mesh
size (Köster et al., 2010) of the VIF network. The contribution of
cytoskeletal ﬁlaments to mechanical properties of living cells is
typically studied using drugs (Cooper, 1987; Yamada et al., 2000).
While a number of selective AF- and MT-drugs is known, the
choice of a suitable drug for selective inhibition of intermediate
ﬁlaments is much more limited. In previous works, VIF disruption
was induced by acrylamide (Eckes et al., 1998; Haudenschild
et al., 2011) which is known to show multiple cytotoxic effects
(Aggeler and Seely, 1990; Arocena; 2006). More recently, the
vimentin disrupting effect of the ayuverdic medicine constituent,
Withaferin-A (WfA), is reported by several authors on the basis of
microscopic imaging or western blots (Thaiparambil et al., 2011;
Grin et al., 2012). WfA treatment leads to dose-dependent reduc-
tion of soluble vimentin forms as well as inhibition of several VIF-
related pathways (Bargagna-Mohan et al., 2013). However,
detailed molecular mechanism of VIF disruption by WfA is not
yet well understood. To our knowledge, effects of WfA on
mechanical cell properties have not been investigated up to now.
1.3. Single cell vs. high-throughput population measurements
Population measurements of rheological cell properties indi-
cate a high degree of cell-to-cell variability (Cai et al., 2013)
suggesting that measurement of a low number of cells may not
be sufﬁcient for statistically consistent characterization on the
population phenotype. Most conventional techniques such as
micropipetting, microplate stretching or atomic force microscopy
are conceptualized for single cell probing and have a limited
throughput capabilities. In this study, we rely on high-through-
put microﬂuidic optical stretching (Guck et al., 2001) which allows
probing of up to 150 cells per hour.
1.4. Cytoskeleton organization in adherent vs. non-adherent cells
Topological and physical boundary conditions have a determin-
ing inﬂuence on organization of cytoskeleton in adherent and
non-adherent cells. While combination of adhesive and gravita-
tional forces promotes formation of complex cytoskeletal struc-
tures in adherent cells, topology of cytoskeleton in suspended cells
reﬂects the intrinsic spherical symmetry of liquid environment
with different groups of ﬁlaments forming shell-like layers around
the nucleus (Zhelev et al., 2001). From this perspective, non-
adherent cells represent a more suitable system for studying the
relationship between material properties the whole cell and a
particular group of cytoskeletal ﬁlaments.
1.5. Computational modeling of cell mechanics
Experimental techniques for probing of cellular mechanics
typically enable measurement of the whole cell properties (i.e.
cell stiffness). In order to dissect the contribution of subcellular
structures to mechanical phenotype of the whole cell, an appro-
priate computational model of constitutive and structural cell
organization is required. Depending on the scale and the goal of
the problem, molecular-, ﬁlament- or continuum-based models
are employed to study mechanics of the whole cell or subcellular
components. Because of the general complexity and heterogeneity
of structural cell organization, consistent meso–macro transitions
are usually applied to simpliﬁed problems, such as 3D simulation
of mono-component network (Kim et al., 2009) or low-dimen-
sional modeling of cellular geometry (Bertaud et al., 2010). In
contrast, continuum models allow an efﬁcient representation of
3D cell shape and subcellular structures, but require a simpliﬁed
description of the constitutive relationships (Milner et al., 2012;
Pachenari et al., 2014). In this work, we apply our previously
developed numerical framework for estimation of constitutive
parameters of subcellular structures by ﬁtting a multi-compo-
nent continuum model of 3D cell mechanics to experimental
image data using the Finite Element Method (Gladilin et al.,
2007; González et al., 2011).
1.6. Summary
Summarizing the above, here we focus on comparative inves-
tigation of the contribution of actin and vimentin intermediate
ﬁlaments to mechanical properties of suspended, non-adherent
Natural Killer (NK) cells. For selective disruption of AF and VIF,
cytoskeletal drugs, Cytochalasin-D (CcD) and Withaferin-A (WfA),
are used. High-throughput population measurements of drug-
treated cells vs. untreated control are performed using microﬂui-
dic optical stretcher (MOS). Subsequent statistical analysis and 3D
Finite Element simulation is performed to gain quantitative
insights into subcellular mechanisms of cell softening induced by
deﬁciency of cortical AF and perinuclear VIF layers.
2. Material and methods
2.1. Cell preparation and drug treatment
NK-92-C1 cells are kindly provided by Prof. Carsten Watzl (University Darm-
stadt, Germany) and cultured in Alpha medium supplemented with 12.5% FCS,
12.5% horse serum, 1% L-glutamine and 1% Penicillin/Streptomycin. For cytoskeleton
disruption experiments, cells are incubated with 4 mM Withaferin-A in DMSO for
3 h or 1 mM Cytochalasin-D for half an hour prior to the measurement of cellular
compliance using an optical stretcher. DMSO treatment is used as control. For
measurements with MOS, 10Eþ5 cells are transferred into 2 ml cryotubes (Neo
Screw-Micro Tube 2 ml, Neolab, Heidelberg, Germany).
2.2. Cell staining and ﬂuorescence imaging
For microscopic screening of cytoskeletal ﬁlaments, cells are ﬁxed, permeabi-
lized, incubated with primary anti-vimentin antibody (kindly provided by Prof.
Harald Herrmann, DKFZ Heidelberg, Germany) and ﬁnally stained with Alexa-
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Fluor-488 conjugated secondary antibody, Rhodamine-Phalloidin and Hoechst
(both purchased from Sigma-Aldrich, St. Louis, USA). Fixes and stained cells are
kept in PBS for microscopy evaluation. All images are acquired at room temperature
with a Leica SP5 laser scanning confocal microscope with a 63 objective and the
LAS software (Leica, Wetzlar, Germany). XYZ image acquisition in sequential scan
mode is used to avoid spectral bleed-through between ﬂuorophores. Contrast
enhanced maximal intensity projections for the different image channels are
generated and subsequently analyzed with ImageJ v1.44 (National Institute of
Health, Bethesda, USA).
2.3. High-throughput deformability measurement using MOS
Measurements of cellular deformability are performed using the microﬂuidic
optical stretcher (MOS) system provided from the Lab of Prof. Josef Kaes (University
Leipzig, Germany). For a detailed description of MOS we refer to Guck et al. (2001).
In brief, the MOS is based on exposing cells to two opposing rays of infrared laser
light (wavelength¼1060 nm) which generates stretching forces on the boundaries
between optically different media. As a result, the cell is continuously stretched
along the laser axis. The successive deformation of the cell is captured in time
series of 2D phase contrast images for subsequent computational image analysis.
The magnitude of the relative cell stretching in MOS is essentially determined by
the laser power which is typically chosen in the range of 400–1000 mW. To avoid
cellular overheating and phototoxicity (Wetzel et al., 2011), a moderate laser power
of 800 mW is used in our experiments to induce sudden cell deformation. Every
cell is monitored 1 s before and after the 2 s rectangle laser pulse which results in a
sequence of totally 120 images. For every time step t¼0–119 of the image sequence,
the outer cell contour is segmented and the diameter of the largest cell axis d(t) is
determined. On the basis of smoothed time series ds(t), the relative stretch of the
cell εðtÞ is computed
εðtÞ ¼ dsðtÞ=d01; ð1Þ
where d0 denotes the diameter of the largest axis of unloaded cells.
2.4. Statistical analysis of cellular deformability measurements
Measurement of the relative stretch in N cells results in a statistical distribution
εi ¼ 1…NðtÞ. Since cell-to-cell variability in population measurements of cellular
deformability is relatively high and the exact type of statistical distribution is
unknown, the parameter-free bootstrap approach is applied for computation of the
empirical distribution of sample means and corresponding conﬁdent intervals
(Efron and Tibshirani, 1993).
2.5. Cell shape analysis
To assess statistical changes in patterns of cellular deformation due to
disruption of AF/VIF layers, average shape models are generated from 2D cell
contours. First, the contour of each cell is normalized by rescaling the bounding box
of the undeformed cell to the square and translating the mass center to (0,0). Then,
contours are uniformly resampled in canonic polar coordinates rðφÞ with 360
sampling points which correspond to 11-stepping of the polar angle φ¼1–3601.
Finally, the average cell shape is computed by constructing the mean of N
normalized contours
ravgðφÞ ¼ ∑
i ¼ 1…N
riðφÞ=N: ð2Þ
2.6. Constitutive cell modeling and parameter estimation
In this study, our focus is on analysis of mechanical cell response during the
force-driven creep phase, i.e., time steps t¼30–89. In the ﬁrst approximation, the
experimental stretch curves (Eq. (1)) can be ﬁt by the viscoelastic Kelvin–Voigt
model
εðtÞ ¼ ε0ð1e t=τÞ; ð3Þ
where ε0 ¼ FðkL0Þ1 is the pure elastic stretch of a 1D Hookean spring with the
initial length L0 and the stiffness k due to application of the force F, and τ is the
characteristic delay (retardation time) of viscoelastic material response to sudden
stress. To account for three-dimensional structure of AF/VIF layers and the whole
cell, the elastic component of cellular deformation is described by the generalized
Hook's law (Ciarlet, 1988)
s¼ CðE; νÞε; ð4Þ
where s denotes the Cauchy stress tensor, ε is the Green–St. Venant strain tensor
and CðE;νÞ is the tensor of elastic constants which in the case of a piecewise
homogeneous material contains only two independent constants, i.e., Young's
modulus (E) and Poisson's ratio (ν). The forces that arise on the cellular boundaries
and trigger the cellular deformation in MOS are approximated by a simpliﬁed stress
proﬁle suggested in Guck et al. (2001)
sr ¼ s0 cos 2ðϑÞ; ð5Þ
where s0 denotes the maximum stress along the main stretching axis and ϑ is
the canonical polar angle. The unknown parameter s0 is estimated iteratively by
ﬁtting the simulated cell stretch to the experimentally observed magnitude of
the relative cellular elongation. Poisson's ratio of the cell is set to ν¼ 0:49. In
accordance with the literature (Guilak et al., 2000), the relative stiffness (RS) of
the nucleus is set ﬁve times higher in comparison to the remaining cytoplasm.
To quantify changes of the relative stiffness of cortical AF and perinuclear VIF
layers due to application of cytoskeletal drugs, simulation of the cellular
deformation is performed iteratively for the range of successfully reduced
stiffness values 0oαo1
RS of the nucleus : VIF : AF ðuntreated cellsÞ : 5 : 1 : 1
RS of the nucleus : VIF : AF ðCcD treated cellsÞ : 5 : 1 : αAF ; 0oαAFo1
RS of the nucleus : VIF : AF ðWfA treated cellsÞ : 5 : αVIF : 1; 0oαVIFo1:
8><
>:
ð6Þ
The sought value of the relative stiffness is determined from the best ﬁt
between the experimentally observed and simulated cellular deformation. For the
detailed description of the FEM-based parameter estimation scheme, we refer to
our previous publications (Gladilin et al., 2007).
3. Results
3.1. Microscopic evaluation of cytoskeletal drug effects
In control conditions, NK cells are characterized by a large
nucleus which takes almost half of the cell volume. The
cytoplasmic layer around the nucleus forms a cage of inter-
twined VIF. A rim of cortical AF can be observed at the cell edge
(Fig. 1A, upper panel). CcD treatment leads to visible dissolu-
tion of cortical AF while perinuclear VIF stay widely unaffected
(Fig. 1A, lower panel). Upon treatment with WfA, the VIF
network is disrupted forming differently shaped aggregates
while the layer of cortical AF still remains visible (Fig. 1A,
middle panel). Notably, a similar nucleation of VIF has been
observed by treatment of cells with body's own chemokines
(Brown et al., 2001; Qi et al., 2006) which indicates that WfA
effects may originate from natural mechanisms of VIF reorga-
nization. The degree of ﬁlament disruption in comparison to
controls is quantiﬁed by measuring the decrease of AF intensity
in CcD treated cells (Fig. 1B) and the accumulation of VIF
aggregates in WfA treated cells (Fig. 1C). Our image analysis
suggests that CcD and WfA induce selective disruption of AF
and VIF in NK cells without statistically signiﬁcant cross-
effects.
3.2. Statistical analysis of deformability measurements
Deformability measurement of NK cells is performed using the
microﬂuidic optical stretcher as described above for totally 420
untreated control, 371 CcD- and 477 WfA-treated cells. To obtain
a statistically signiﬁcant ﬁngerprint of untreated and drug-
treated cell populations, bootstrap mean-values and 95%-conﬁ-
dence intervals of the relative cell stretch are calculated from the
entity εi ¼ 1…NðtÞ of N measured cells. As one can see in Fig. 2,
application of CcD and WfA results in statistically signiﬁcant
softening of NK cells in comparison to untreated control. By the
end of the creep phase (t¼89), the relative stretch of untreated,
1 mM WfA- and 4 mM CcD-treated probes amounts to 7.3%, 8.8%
and 10.3%, respectively, which means that AF and VIF deﬁcient
NK cells are, in average, 41% and 20% softer than untreated
control. Remarkably, the creep curves of all three conditions
exhibit similar time-patterns of cellular elongation. The ﬁt of
creep curves with the Kelvin–Voigt model (Eq. (3)) conﬁrms that
drug-treated cells do not signiﬁcantly differ from untreated
control with respect to the retardation time, which lays by
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τ¼3.4 s. In the recovery phase (t¼90–119), CcD-treated
cells show more rapid recovery rate of 50% than untreated and
WfA-treated cells that recover only 30% of their maximum
relative elongation within the same time frame. Similar to Guo
et al. (2013), we observe that WfA softens the cellular interior
while CcD causes destabilization of outer cellular contours and,
Fig. 1. Changes in vimentin and actin organization upon drug-treatment. A. Maximal intensity projections of exemplary images showing the nuclear, VIF and AF in stained
NK cells. In control conditions (upper panel) VIF form a network caging the nuclei of NK cells while a cortical actin rim is observed along the cell edge. Treatment with
Withaferin-A (middle panel) causes aggregation of vimentin while the cortical actin remains visible. Incubation with Cytochalasin-D, on the other hand, results in disruption
of the rim of cortical actin (lower panel). Scale bar¼5 mm. B. Quantiﬁcation of AF disruption upon drug treatment. The average intensity of the summed maximal projection
of actin stained cells is quantiﬁed for 10 cells of each condition. The strongest decrease in AF intensity is measured in the CcD treated cells. C. Quantiﬁcation of VIF disruption
upon drug treatment. Treatment with Withaferin-A does not have an effect on the total ﬂuorescent intensity of VIF, but it is quantiﬁed on the average ﬁlaments size in the 2D
image slices of the vimentin stained cells. Only the WfA treated cells show that strong accumulation of VIF to dot- and stripe-like structures (yellow) (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
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consequently, higher cytotoxicity, see Fig. 3. To generalize iso-
lated observations, statistical shape models of drug-treated and
untreated cells are generated, see Fig. 4. The differences in
statistical shape changes conﬁrm our microscopic ﬁndings that
CcD and WfA selectively disrupt cortical AF and perinuclear VIF in
NK cells.
Fig. 2. Average creep-and-recovery curves depict mechanical ﬁngerprints of drug-treated and untreated NK cells in MOS. Mean values of the relative cell stretch and
conﬁdence intervals are computed using the bootstrap simulation. At the end of the creep-phase (t¼89), the relative elongation of untreated, WfA- and CcD-treated NK cells
amounts, in population average, to 7.3%, 8.8% and 10.3%, respectively. Thus, CcD-treated (red) and WfA-treated NK cells (green) show 41% and 20% larger stretch in
comparison to untreated control (blue). In the recovery phase (t¼90–119), WfA-treated cells show no signiﬁcant difference to untreated control, while CcD-treated cells
exhibit faster recovery than untreated control (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
Fig. 3. From left to right: examples of phase contrast images acquired with MOS show undeformed conﬁguration (time step t¼0), maximum deformation (time step t¼89)
and 1 s relaxation (time step t¼119) of CcD-treated (top row) and WfA-treated (bottom row) NK cells. Yellow arrows indicate the main stretching axis. AF deﬁcient cells
(upper row) exhibit larger deformation and more irregular contours in comparison to VIF deﬁcient cells due destabilization of the cortical ﬁlaments network (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article).
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Fig. 4. Normalized contours of WfA-treated (left) and CcD-treated (right) NK cells. Statistical shape models of undeformed conﬁguration (green) and maximum deformation
(blue) of NK cells are generated by normalizing and averaging of cell contours from each drug-treated or untreated population (gray), respectively (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article).
Fig. 5. Top, left: three-component FE model of a NK cell including the nucleus (violet), cortical AF (red) and perinuclear VIF (green) layers. Top, right: distribution of the
maximum local strain in the perinuclear VIF layer of the stretched untreated cell. The color map (from 0% (dark blue) to 24% (red)) indicates the local magnitude of the
maximum Eigenvalue of the strain tensor. Bottom: plots of the error norm between simulated and experimental cell deformation as a function of the relative stiffness of AF
(red) and VIF (green) layers. The sought values of the relative stiffness correspond to the minimum error norm (i.e., EN¼0) (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article).
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3.3. Dissecting intracellular mechanics using the 3D FE model
To establish a quantitative relationship between softening of AF/
VIF layers and 3D cell deformation, a three-component FE mesh
model of the NK cell is generated using Amira 4.1 (Mercury
Computer Systems, Chelmsford, USA), see Fig. 5 (top row, left). On
the basis of image analysis, we consider the unloaded cell to be
spherical with the nucleus taking the half of the cell volume
(i.e., the nuclear radius¼78% of the cellular radius). Accordingly,
perinuclear VIF and cortical AF layers are assumed to be non-
overlapping shells of equal thickness that occupy the remaining
cytoplasm in the radial range of 78–89% (VIF) and 89–100% (AF),
respectively. The basic idea of our FEM-based parameter estimation
scheme consists in ﬁnding the set of material cell parameters with
the best ﬁt between the simulated and experimentally observed
cellular deformation. Here, our focus is on quantiﬁcation of the
relative changes in AF/VIF stiffness upon drug-treatment. Since the
time-dependent damping factor ð1e t=τÞ in Eq. (3) turns out to be
equal for drug-treated and untreated NK cells, it is factored out by
calculation of the relative changes in cellular deformability using the
pure elastic material approximation. The boundary conditions for the
simulation of cellular deformation are given by the simpliﬁed stress
proﬁle (Eq. (5)). For every combination of the relative stiffness values
of the three-component cell model (Eq. (6)), the deviation of the
simulated cell elongation from the reference conﬁguration is scored
using the following L1 error norm:
 Simulation of AF softening: ENðαAF Þ ¼ ‖1:41 maxðεtðαAF ÞÞ=
maxðεuÞ‖; Simulation of VIF softening: ENðαVIF Þ ¼ ‖1:20 maxðεtðαVIF ÞÞ=
maxðεuÞ‖;
where εtðαÞ indicates the maximum relative stretch of the cell
computed with the FEM for the variable relative stiffness 0oαo1
of AF/VIF layers and εu is the maximum relative stretch of the
reference model corresponding to the untreated cell (i.e., α¼ 1).
Fig. 5 (bottom row) shows the plots of the simulated error norm as
a function of the variable AF/VIF stiffness. The sought values of the
relative stiffness of AF/VIF layers corresponding to the minimum of
the error norm between simulated and experimental data are
found to be αAF ¼ 0:34 and αVIF ¼ 0:52 which suggest a decrease of
the relative AF/VIF stiffness by (0.34–1)100%¼66% and
(0.521)100%¼48%, respectively. To quantify the strain state
of the VIF layer, the maximum strain Eigenvalue is computed on
tetrahedrons of the FE mesh, see Fig. 5 (top row, right). As
expected, the maximum strain of VIF is generated along the main
stretching axis of the cell and amounts to 23.7%, 37.5% and 52.6% in
untreated, WfA- and CcD-treated NK cells, respectively.
4. Discussion
Our experimental results show that under impact of sudden
stress induced by 2 s 800 mW laser pulse, untreated, 4 mM WfA-
treated (VIF deﬁcient) and 1 mM CcD-treated (AF deﬁcient) NK cells
exhibit statistically signiﬁcant differences in the relative elonga-
tion which amounts to 7.3%, 8.8% and 10.3%, respectively. Accord-
ing to our FE simulation, experimentally observed softening of
CcD- and WfA-treated NK cells by 41% and 20% relatively to
untreated control is associated with the decrease of the relative
AF and VIF stiffness by 66% and 48% (see Table 1). Our
microscopic imaging and statistical shape analysis suggests that
CcD and WfA selectively target cortical AF and perinuclear VIF
layers in NK cells without signiﬁcant cross-effects. While CcD
inhibits AF polymerization, the effect of WfA consists presumably
in coarsening of the VIF network. Despite the differences in
molecular mechanisms of AF and VIF disruption by CcD and
WfA, cell softening in both cases can be attributed to reduction
of the effective density and, consequently, stiffness of ﬁlament
networks (Wakatsuki et al., 2001; Bertaud et al., 2010; Köster et al.,
2010).
Further, our FE model predicts that relatively moderate cell
elongation (7–10%) is associated with signiﬁcantly higher strain rates
in the perinuclear VIF layer ranging from 24% in untreated to 38% and
52% in WfA- and CcD-treated cells, respectively (see Table 2). This
difference is a direct consequence of the higher stiffness of the
relatively large nucleus in NK cells. Consequently, the thin and soft
cytoplasm undergoes larger relative deformations as the entire cell.
According to molecular simulations of VIF mechanics in Qin et al.
(2009), the estimated order of maximum VIF strains in our experi-
ments corresponds to the ﬁrst two (I and II) linear regimes of VIF
deformation that are associated with stretching and unfolding of
vimentin alpha-helices. Larger strain rates that would enable probing
of higher hierarchical levels of mechanical VIF organization in living
cells are not accessible with the MOS because of the severe side-
effects of high-energy laser radiation.
More than two-fold increase of the perinuclear VIF strain in AF
deﬁcient cells indicates that the mechanical function of VIF as a
Table 1
Summary of the results from MOS measurements and FE simulation: increase of the whole cell deformability vs. decrease of the
relative stiffness of AF/VIF layers.
Effects of drug-induced deﬁciency Increase of the whole cell
deformability (MOS measurements)
Decrease of the relative stiffness
of AF/VIF layers (FE simulation)
Actin (AF) (1 mM CcD) þ41% w.r.t. untreated control 66% w.r.t. untreated control
Vimentin (VIF) (4 mM WfA) þ20% w.r.t. untreated control 48% w.r.t. untreated control
Table 2
Summary of the results from MOS measurements and FE simulation: maximum relative stretch of the whole cell by the end of the
creep phase (t¼89) vs. maximum strain of the VIF layer.
Effects of drug-induced deﬁciency Max. relative stretch of the
whole cell (MOS measurements) (%)
Max. strain of the VIF layer
(FE simulation) (%)
Untreated 7.3 23.7
Vimentin (VIF) (4 mM WfA) 8.8 37.5
Actin (AF) (1 mM CcD) 10.3 52.6
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protective buffer of the chromatin-bearing nucleus becomes
particularly essential in motile and proliferating cells that have
to dynamically remodel their cortical AF network. Here, our data
adds a functional explanation to frequently observed emergence of
vimentin as a marker of epithelial–mesenchymal and metastatic
transitions (Willipinski-Stapelfeldt et al., 2005), and underlines the
role of VIF targeting drugs, such as WfA, as a low-toxic cancero-
static supplement.
Our present experimental and computational framework is
designed to combine high-throughput population measurements
of cellular compliance with the basic structural analysis of three-
dimensional cell mechanics at a 1 mm scale which corresponds to
the estimated thickness of AF/VIF layers in our FE cell model.
Consideration of mechanical properties of cytoskeletal ﬁlaments is
generally possible within the scope of a continuum model, i.e.,
by construction of an appropriate mesoscopic tensor of viscoelastic
constants. Though, a consistent evaluation of higher-order consti-
tutive models of cellular matter is more feasible in conjunction
with controlled mechanical micromanipulation and high-resolu-
tion imaging of single cells or synthetic ﬁlament samples.
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